SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Comment Letter for AMERICAN VANGUARD (AVD) — Aug 27, 2025

AMERICAN VANGUARD CORP
Date: Aug. 27, 2025 · CIK: 0000005981 · Accession: 0000000000-25-009186

AI Filing Summary & Sentiment

File numbers found in text: 001-13795

Date
August 27, 2025
Author
Not clearly detected
Form
UPLOAD
Company
AMERICAN VANGUARD CORP

Letter

August 27, 2025 David Johnson Chief Financial Officer AMERICAN VANGUARD CORP 4695 MacArthur Court Newport Beach, CA 92660 Re:AMERICAN VANGUARD CORP Form 10-K filed May 29, 2025 Form 8-K filed March 14, 2025 File No. 001-13795 Dear David Johnson: We have reviewed your filing and have the following comments. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Form 10-K filed May 29, 2025 Results of Operations, page 22 1.Given the material impact of transformation expenses on your 2024 operating results, please disaggregate the material components of this expense category. The expanded disclosure should clarify why these costs are characterized on page 21 as non- recurring. In this regard, it appears that this category includes expenses for compensation, strategic planning and information system upgrades that would appear to constitute normal and recurring cash operating expenses that are necessary to operate your business. Liquidity and Capital Resources, page 24 2.Please disclose whether the Adjusted EBITDA amounts provided in your Forms 8-K can be used to assess your compliance with the minimum year-to-date consolidated EBITDA financial debt covenants referenced on page 27. In this regard, it is not clear whether the measures are equivalent. Critical Accounting Estimates, page 27 If material, please expand your disclosure to address any intangible assets 3.

August 27, 2025 Page 2 corresponding to your operations in countries for which you have recorded a full deferred tax asset valuation allowance. Based on the existing disclosure, it is not clear whether such intangible assets are material or whether the associated recoverability estimates are impacted by known adverse facts and circumstances. Major Customers, page 56 4.It is not clear whether the revenues corresponding to any individual countries in your South and Central America category should be separately disclosed pursuant to ASC 280-10-50-41. Please tell us the three countries that primarily comprise the December 31, 2024 South and Central America revenue amount and quantify each country's revenue. Tell us also the three countries that comprise the largest components of the 2024 international intangible assets balance on page 59 and quantify the corresponding asset balances. In addressing your consideration of the disclosure guidance, please include a substantive analysis of the extent to which the sales growth and profit margins of your operations in the individual countries materially differ from your consolidated operating results. For example, the disclosure on page 53 infers continuing adverse operating results in your Brazilian operations, but the magnitude of those operations and the carrying value of any assets at risk do not appear to be disclosed either in the financial statements or in MD&A. Form 8-K filed March 14, 2025 Exhibit 99.1, page 1 5.Please clarify for us how you considered the guidance in Item 10(e)(1)(i) of Regulation S-K when excluding an estimate of the most directly comparable GAAP performance measure from your disclosure. It is also not clear why a reconciliation between Adjusted EBITDA and the comparable GAAP measure was omitted. Further, it does not appear that you have disclosed the reasons why you believe that Adjusted EBITDA provides useful information to investors. Additionally, it is not clear whether you use the non-GAAP financial measure for additional purposes. See Instruction 2 to Item 2.02 of Form 8-K. 6.Please tell us the extent to which your final fiscal 2024 Adjusted EBITDA results differed from your $42m preliminary estimate. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Al Pavot at 202-551-3738 or Terence O'Brien at 202- 551-3355 if you have questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services

Show Raw Text
August 27, 2025
David Johnson
Chief Financial Officer
AMERICAN VANGUARD CORP
4695 MacArthur Court
Newport Beach, CA 92660
Re:AMERICAN VANGUARD CORP
Form 10-K filed May 29, 2025
Form 8-K filed March 14, 2025
File No. 001-13795
Dear David Johnson:
            We have reviewed your filing and have the following comments. Please respond to
this letter within ten business days by providing the requested information or advise us as
soon as possible when you will respond. If you do not believe a comment applies to your
facts and circumstances, please tell us why in your response. After reviewing your response
to this letter, we may have additional comments.
Form 10-K filed May 29, 2025
Results of Operations, page 22
1.Given the material impact of transformation expenses on your 2024 operating results,
please disaggregate the material components of this expense category. The expanded
disclosure should clarify why these costs are characterized on page 21 as non-
recurring. In this regard, it appears that this category includes expenses for
compensation, strategic planning and information system upgrades that would appear
to constitute normal and recurring cash operating expenses that are necessary to
operate your business.
Liquidity and Capital Resources, page 24
2.Please disclose whether the Adjusted EBITDA amounts provided in your Forms 8-K
can be used to assess your compliance with the minimum year-to-date consolidated
EBITDA financial debt covenants referenced on page 27. In this regard, it is not clear
whether the measures are equivalent.
Critical Accounting Estimates, page 27
If material, please expand your disclosure to address any intangible assets 3.

August 27, 2025
Page 2
corresponding to your operations in countries for which you have recorded a full
deferred tax asset valuation allowance. Based on the existing disclosure, it is not clear
whether such intangible assets are material or whether the associated recoverability
estimates are impacted by known adverse facts and circumstances.
Major Customers, page 56
4.It is not clear whether the revenues corresponding to any individual countries in your
South and Central America category should be separately disclosed pursuant to ASC
280-10-50-41. Please tell us the three countries that primarily comprise the December
31, 2024 South and Central America revenue amount and quantify each country's
revenue. Tell us also the three countries that comprise the largest components of the
2024 international intangible assets balance on page 59 and quantify the
corresponding asset balances. In addressing your consideration of the disclosure
guidance, please include a substantive analysis of the extent to which the sales growth
and profit margins of your operations in the individual countries materially differ from
your consolidated operating results. For example, the disclosure on page 53 infers
continuing adverse operating results in your Brazilian operations, but the magnitude
of those operations and the carrying value of any assets at risk do not appear to be
disclosed either in the financial statements or in MD&A.
Form 8-K filed March 14, 2025
Exhibit 99.1, page 1
5.Please clarify for us how you considered the guidance in Item 10(e)(1)(i) of
Regulation S-K when excluding an estimate of the most directly comparable GAAP
performance measure from your disclosure. It is also not clear why a reconciliation
between Adjusted EBITDA and the comparable GAAP measure was omitted. Further,
it does not appear that you have disclosed the reasons why you believe that Adjusted
EBITDA provides useful information to investors. Additionally, it is not clear whether
you use the non-GAAP financial measure for additional purposes. See Instruction 2 to
Item 2.02 of Form 8-K.
6.Please tell us the extent to which your final fiscal 2024 Adjusted EBITDA results
differed from your $42m preliminary estimate.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence
of action by the staff. Please contact Al Pavot at 202-551-3738 or Terence O'Brien at 202-
551-3355 if you have questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services